What we have learned about intrapartum fetal monitoring trials in the MFMU Network

Steven L. Bloom, Michael Belfort, George Saade

    Research output: Contribution to journalArticle

    4 Citations (Scopus)

    Abstract

    The vast majority of pregnant women are subjected to electronic fetal heart monitoring during labor. There is limited evidence to support its benefit compared with intermittent auscultation. In addition, there is significant variability in interpretation and its false-positive rate is high. The latter may have contributed to the rise in operative deliveries. In order to address the critical need for better approaches to intrapartum monitoring, the MFMU Network has completed two large multisite randomized trials, one to evaluate fetal pulse oximetry and the other to evaluate fetal ECG ST segment analysis (STAN). Both of these technologies had been approved for clinical use in the United States based on prior smaller trials. These technologies were evaluated in laboring women near term and their primary outcomes were overall cesarean delivery for the oximetry trial and a composite adverse neonatal outcome for STAN. Both the trials failed to show a benefit of the technology, neither in the rates of operative deliveries nor in the rates of adverse neonatal outcomes. The experience with these trials, summarized in this report, highlights the need for rigorous evidence before introduction of new technology into clinical practice and provides a blueprint for future trials to address the need for better intrapartum monitoring approaches.

    Original languageEnglish (US)
    JournalSeminars in Perinatology
    DOIs
    StateAccepted/In press - 2016

    Fingerprint

    Fetal Monitoring
    Technology
    Oximetry
    Cardiotocography
    Auscultation
    Fetal Heart
    Pregnant Women
    Electrocardiography

    Keywords

    • Fetal pulse oximetry
    • Fetal ST segment analysis
    • Intrapartum fetal monitoring

    ASJC Scopus subject areas

    • Pediatrics, Perinatology, and Child Health
    • Obstetrics and Gynecology

    Cite this

    What we have learned about intrapartum fetal monitoring trials in the MFMU Network. / Bloom, Steven L.; Belfort, Michael; Saade, George.

    In: Seminars in Perinatology, 2016.

    Research output: Contribution to journalArticle

    @article{c360789bd16b4eadb8d95053614dd53d,
    title = "What we have learned about intrapartum fetal monitoring trials in the MFMU Network",
    abstract = "The vast majority of pregnant women are subjected to electronic fetal heart monitoring during labor. There is limited evidence to support its benefit compared with intermittent auscultation. In addition, there is significant variability in interpretation and its false-positive rate is high. The latter may have contributed to the rise in operative deliveries. In order to address the critical need for better approaches to intrapartum monitoring, the MFMU Network has completed two large multisite randomized trials, one to evaluate fetal pulse oximetry and the other to evaluate fetal ECG ST segment analysis (STAN). Both of these technologies had been approved for clinical use in the United States based on prior smaller trials. These technologies were evaluated in laboring women near term and their primary outcomes were overall cesarean delivery for the oximetry trial and a composite adverse neonatal outcome for STAN. Both the trials failed to show a benefit of the technology, neither in the rates of operative deliveries nor in the rates of adverse neonatal outcomes. The experience with these trials, summarized in this report, highlights the need for rigorous evidence before introduction of new technology into clinical practice and provides a blueprint for future trials to address the need for better intrapartum monitoring approaches.",
    keywords = "Fetal pulse oximetry, Fetal ST segment analysis, Intrapartum fetal monitoring",
    author = "Bloom, {Steven L.} and Michael Belfort and George Saade",
    year = "2016",
    doi = "10.1053/j.semperi.2016.03.008",
    language = "English (US)",
    journal = "Seminars in Perinatology",
    issn = "0146-0005",
    publisher = "W.B. Saunders Ltd",

    }

    TY - JOUR

    T1 - What we have learned about intrapartum fetal monitoring trials in the MFMU Network

    AU - Bloom, Steven L.

    AU - Belfort, Michael

    AU - Saade, George

    PY - 2016

    Y1 - 2016

    N2 - The vast majority of pregnant women are subjected to electronic fetal heart monitoring during labor. There is limited evidence to support its benefit compared with intermittent auscultation. In addition, there is significant variability in interpretation and its false-positive rate is high. The latter may have contributed to the rise in operative deliveries. In order to address the critical need for better approaches to intrapartum monitoring, the MFMU Network has completed two large multisite randomized trials, one to evaluate fetal pulse oximetry and the other to evaluate fetal ECG ST segment analysis (STAN). Both of these technologies had been approved for clinical use in the United States based on prior smaller trials. These technologies were evaluated in laboring women near term and their primary outcomes were overall cesarean delivery for the oximetry trial and a composite adverse neonatal outcome for STAN. Both the trials failed to show a benefit of the technology, neither in the rates of operative deliveries nor in the rates of adverse neonatal outcomes. The experience with these trials, summarized in this report, highlights the need for rigorous evidence before introduction of new technology into clinical practice and provides a blueprint for future trials to address the need for better intrapartum monitoring approaches.

    AB - The vast majority of pregnant women are subjected to electronic fetal heart monitoring during labor. There is limited evidence to support its benefit compared with intermittent auscultation. In addition, there is significant variability in interpretation and its false-positive rate is high. The latter may have contributed to the rise in operative deliveries. In order to address the critical need for better approaches to intrapartum monitoring, the MFMU Network has completed two large multisite randomized trials, one to evaluate fetal pulse oximetry and the other to evaluate fetal ECG ST segment analysis (STAN). Both of these technologies had been approved for clinical use in the United States based on prior smaller trials. These technologies were evaluated in laboring women near term and their primary outcomes were overall cesarean delivery for the oximetry trial and a composite adverse neonatal outcome for STAN. Both the trials failed to show a benefit of the technology, neither in the rates of operative deliveries nor in the rates of adverse neonatal outcomes. The experience with these trials, summarized in this report, highlights the need for rigorous evidence before introduction of new technology into clinical practice and provides a blueprint for future trials to address the need for better intrapartum monitoring approaches.

    KW - Fetal pulse oximetry

    KW - Fetal ST segment analysis

    KW - Intrapartum fetal monitoring

    UR - http://www.scopus.com/inward/record.url?scp=84964625760&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84964625760&partnerID=8YFLogxK

    U2 - 10.1053/j.semperi.2016.03.008

    DO - 10.1053/j.semperi.2016.03.008

    M3 - Article

    JO - Seminars in Perinatology

    JF - Seminars in Perinatology

    SN - 0146-0005

    ER -